Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial 23S ribosomal RNA of the 50S subunit is a large, non-coding RNA (~2,900 nucleotides in E. coli) that forms the catalytic core of the bacterial large ribosomal subunit (50S). It organizes six secondary structure domains, with domain V housing the peptidyl transferase center—essential for protein synthesis and responsible for peptide bond formation. Numerous antibiotics inhibit bacterial growth by binding to specific sites within 23S rRNA (chiefly in domain V), effectively blocking translation; mutations and modifications in 23S rRNA confer resistance to many classes of antibacterial drugs. Thus, 23S rRNA is critically important both for cell viability and as a therapeutic target for antibiotics. Its molecular architecture and function distinguish it from eukaryotic ribosomes, facilitating selective inhibition by antibiotics.
Inhibit peptide bond formation by blocking the peptidyl transferase center; Prevent binding of aminoacyl- or peptidyl-tRNA; Disturb translocation of tRNA and mRNA; Induce ribosomal stalling or premature termination of protein synthesis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 23S ribosomal RNA of the 50S subunit (23S rRNA).